Kwai Logo
Kwai User Avatar
A Agência Nacional de Vigilância Sanitária aprovou o Wegovy , o primeiro medicamento de uso semanal para tratamento obesidade e o sobrepeso. A decisão foi publicada nesta segunda-feira, 2, no Diário Oficial da União. O medicamento é produzido pela farmacêutica Novo Nordisk e age da mesma maneira que Ozempic, indicado para diabetes tipo 2. #obesidade #medicamento
42
Comentar
Baixar
Carregando
kwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwai